These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 17237435)

  • 21. The influence of corticosteroids on the release of novel biomarkers in human endotoxemia.
    de Kruif MD; Lemaire LC; Giebelen IA; Struck J; Morgenthaler NG; Papassotiriou J; Elliott PJ; van der Poll T
    Intensive Care Med; 2008 Mar; 34(3):518-22. PubMed ID: 18080111
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of IC14, an anti-CD14 antibody, on coagulation and fibrinolysis during low-grade endotoxemia in humans.
    Verbon A; Meijers JC; Spek CA; Hack CE; Pribble JP; Turner T; Dekkers PE; Axtelle T; Levi M; van Deventer SJ; Reitsma PH; van der Poll T
    J Infect Dis; 2003 Jan; 187(1):55-61. PubMed ID: 12508146
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recombinant human activated protein C (rhAPC; drotrecogin alfa [activated]) has minimal effect on markers of coagulation, fibrinolysis, and inflammation in acute human endotoxemia.
    Derhaschnig U; Reiter R; Knöbl P; Baumgartner M; Keen P; Jilma B
    Blood; 2003 Sep; 102(6):2093-8. PubMed ID: 12750166
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recombinant human antithrombin inhibits thrombin formation and interleukin 6 release in human endotoxemia.
    Leitner JM; Firbas C; Mayr FB; Reiter RA; Steinlechner B; Jilma B
    Clin Pharmacol Ther; 2006 Jan; 79(1):23-34. PubMed ID: 16413239
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of interleukin-6 blockade on tissue factor-induced coagulation in human endotoxemia.
    Derhaschnig U; Bergmair D; Marsik C; Schlifke I; Wijdenes J; Jilma B
    Crit Care Med; 2004 May; 32(5):1136-40. PubMed ID: 15190963
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic, and complement pathways.
    van Deventer SJ; Büller HR; ten Cate JW; Aarden LA; Hack CE; Sturk A
    Blood; 1990 Dec; 76(12):2520-6. PubMed ID: 2124934
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hyperglycemia enhances coagulation and reduces neutrophil degranulation, whereas hyperinsulinemia inhibits fibrinolysis during human endotoxemia.
    Stegenga ME; van der Crabben SN; Blümer RM; Levi M; Meijers JC; Serlie MJ; Tanck MW; Sauerwein HP; van der Poll T
    Blood; 2008 Jul; 112(1):82-9. PubMed ID: 18316629
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of the pan-selectin antagonist bimosiamose (TBC1269) in experimental human endotoxemia.
    Mayr FB; Firbas C; Leitner JM; Spiel AO; Reiter RA; Beyer D; Meyer M; Wolff G; Jilma B
    Shock; 2008 Apr; 29(4):475-82. PubMed ID: 18598003
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhaled unfractionated heparin improves abnormalities of alveolar coagulation, fibrinolysis and inflammation in endotoxemia-induced lung injury rats.
    Wang ZY; Wu SN; Zhu ZZ; Yang BX; Zhu X
    Chin Med J (Engl); 2013 Jan; 126(2):318-24. PubMed ID: 23324284
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics and pharmacodynamics of the dual FII/FX inhibitor BIBT 986 in endotoxin-induced coagulation.
    Leitner JM; Jilma B; Mayr FB; Cardona F; Spiel AO; Firbas C; Rathgen K; Stähle H; Schühly U; Graefe-Mody EU
    Clin Pharmacol Ther; 2007 Jun; 81(6):858-66. PubMed ID: 17410124
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Establishment of a low dose canine endotoxemia model to test anti-inflammatory drugs: effects of prednisolone.
    De Vries F; Leuschner J; Jilma B; Derhaschnig U
    Int J Immunopathol Pharmacol; 2013; 26(4):861-9. PubMed ID: 24355221
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Contribution of interleukin-1 to activation of coagulation and fibrinolysis, neutrophil degranulation, and the release of secretory-type phospholipase A2 in sepsis: studies in nonhuman primates after interleukin-1 alpha administration and during lethal bacteremia.
    Jansen PM; Boermeester MA; Fischer E; de Jong IW; van der Poll T; Moldawer LL; Hack CE; Lowry SF
    Blood; 1995 Aug; 86(3):1027-34. PubMed ID: 7620156
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of supra-normal protein C levels on markers of coagulation, fibrinolysis and inflammation in a human model of endotoxemia.
    Spiel AO; Firbas C; Mayr FB; Leitner JM; Schmidt B; Knöbl P; Varadi K; Jilma B
    Thromb Haemost; 2005 Dec; 94(6):1148-55. PubMed ID: 16411386
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elimination of interleukin 6 attenuates coagulation activation in experimental endotoxemia in chimpanzees.
    van der Poll T; Levi M; Hack CE; ten Cate H; van Deventer SJ; Eerenberg AJ; de Groot ER; Jansen J; Gallati H; Büller HR
    J Exp Med; 1994 Apr; 179(4):1253-9. PubMed ID: 8145042
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential effects of anti-tumor necrosis factor monoclonal antibodies on systemic inflammatory responses in experimental endotoxemia in chimpanzees.
    van der Poll T; Levi M; van Deventer SJ; ten Cate H; Haagmans BL; Biemond BJ; Büller HR; Hack CE; ten Cate JW
    Blood; 1994 Jan; 83(2):446-51. PubMed ID: 8286742
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of intra-abdominal administration of recombinant tissue plasminogen activator on coagulation, fibrinolysis and inflammatory responses in experimental polymicrobial peritonitis.
    van Veen SQ; Meijers JC; Levi M; van Gulik TM; Boermeester MA
    Shock; 2007 May; 27(5):534-41. PubMed ID: 17438459
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tissue factor pathway inhibitor does not influence inflammatory pathways during human endotoxemia.
    de Jonge E; Dekkers PE; Creasey AA; Hack CE; Paulson SK; Karim A; Kesecioglu J; Levi M; van Deventer SJ; van der Poll T
    J Infect Dis; 2001 Jun; 183(12):1815-8. PubMed ID: 11372037
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phosphodiesterase inhibition decreases nuclear factor-kappaB activation and shifts the cytokine response toward anti-inflammatory activity in acute endotoxemia.
    Coimbra R; Melbostad H; Loomis W; Tobar M; Hoyt DB
    J Trauma; 2005 Sep; 59(3):575-82. PubMed ID: 16361898
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Blockade of GPIIb/IIIa by eptifibatide and tirofiban does not alter tissue factor induced thrombin generation in human endotoxemia.
    Derhaschnig U; Pachinger C; Schweeger-Exeli I; Marsik C; Jilma B
    Thromb Haemost; 2003 Dec; 90(6):1054-60. PubMed ID: 14652636
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation of coagulation and inhibition of fibrinolysis in the human lung on bronchial instillation of lipoteichoic acid and lipopolysaccharide.
    Hoogerwerf JJ; de Vos AF; Levi M; Bresser P; van der Zee JS; Draing C; von Aulock S; van der Poll T
    Crit Care Med; 2009 Feb; 37(2):619-25. PubMed ID: 19114879
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.